Clinical trial

The Incidence of Hypocalcemia in Pregnant Women at Siriraj Hospital

Name
Si 1003/2021
Description
Calcium is an essential element for fundamental physiological functions and during pregnancy. However, higher calcium intake can induce constipation, flatulence, nausea, or kidney stones. This study aims to evaluate the incidence of hypocalcemia among pregnant women in the first half of pregnancy in Thailand. Also, Comparison of calcium level in pregnant women in the third trimester who received and not received calcium during pregnancy.
Trial arms
Trial start
2022-05-05
Estimated PCD
2023-09-12
Trial end
2024-05-31
Status
Active (not recruiting)
Treatment
Calcium supplement
Different amount of calcium supplement in pregnancy
Arms:
Hypocalcemia level with receiving calcium supplement 2g/day, Hypocalcemia with receiving calcium supplement 1g/day, Normal calcium level with receiving calcium supplement 1g/day
Size
444
Primary endpoint
The incidence of hypocalcemia in pregnant women at Siriraj Hospital
1.5 year
Eligibility criteria
Inclusion Criteria: * Pregnant women who attend antenatal care clinic in Siriraj Hospital * Pregnant women with gestation less than 20 weeks of gestation * Singleton pregnancy Exclusion Criteria: * Pregnant women who has underlying diseases including liver disease and vitamin D deficiency * Pregnant women are malnutrition patients * Pregnant women who receive calcium supplement before enrollment
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'OTHER', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 444, 'type': 'ESTIMATED'}}
Updated at
2023-12-07

1 organization

1 product

1 indication

Organization
Siriraj Hospital
Product
Calcium
Indication
Hypocalcemia